Cite

HARVARD Citation

    Shcherbinin, S. et al. (n.d.). TRAILBLAZER‐ALZ Study: Dynamics of amyloid reduction after donanemab treatment. Alzheimer's & dementia. p. n/a. [Online]. 
  
Back to record